Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04968106
Title Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Retroperitoneal Sarcomas (TORNADO) (TORNADO)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonié

retroperitoneal sarcoma


Doxorubicin + Ifosfamide

Doxorubicin + Ifosfamide + Retifanlimab

Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.